Sheep And Goat Pox Vaccines Market Report 2026

Sheep And Goat Pox Vaccines Market Overview

• Sheep And Goat Pox Vaccines market size has reached to $60.43 billion in 2025 • Expected to grow to $73.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.9% • Growth Driver: Growing Demand For Livestock Products Fuels Sheep And Goat Pox Vaccines Market • Market Trend: Strategic Collaborations Advancing Comprehensive Livestock Vaccination Solutions • North America was the largest region in 2025.

What Is Covered Under Sheep And Goat Pox Vaccines Market?

Sheep and goat pox vaccines refer to vaccines developed to prevent diseases caused by the sheep pox and goat pox viruses, which belong to the Capripoxvirus genus. These vaccines are crucial for the prevention and control of outbreaks in sheep and goat populations, as both diseases can cause significant economic losses due to high mortality rates and decreased productivity. The vaccines work by stimulating the immune system to produce antibodies against the viruses, providing protection against infection. The main types of sheep and goat pox vaccines are live attenuated vaccines, inactivated vaccines, and others. Live-attenuated vaccines are a type of vaccine that uses weakened or attenuated forms of the virus. These vaccines are designed to stimulate the immune system without causing severe illness. They are often used for diseases where a strong immune response is necessary for protection, such as sheep and goat pox. The different routes of administration includes injectable, intranasal, and involves various applications such as sheep and goat.

What Is The Sheep And Goat Pox Vaccines Market Growth Forecast?

The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $73.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to advancements in recombinant and dna-based vaccine technologies, increasing demand for adjuvanted inactivated vaccines, expansion of preventive veterinary healthcare programs, rising livestock farming investments, growing awareness of biosecurity measures in animal husbandry. Major trends in the forecast period include development of multivalent vaccines for broader protection, rising adoption of injectable vaccines in livestock, increased focus on recombinant and dna-based vaccines, growing awareness of sheep and goat disease prevention, expansion of veterinary vaccination programs in rural regions.

Global Sheep And Goat Pox Vaccines Market Segmentation

1) By Type: Live Attenuated Vaccines, Inactivated Vaccines, Other Types 2) By Route Of Administration: Injectable, Intranasal 3) By Application: Sheep, Goat Subsegments: 1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines 2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines 3) By Other Types: Recombinant Vaccines, DNA-Based Vaccines

What Are The Drivers Of The Sheep And Goat Pox Vaccines Market?

The growing demand for livestock products is expected to propel the growth of the sheep and goat pox vaccines market going forward. Livestock products refer to the various goods and materials derived from domesticated animals raised in agricultural settings. The increasing demand for livestock products is driven by several factors, including income and population growth, urbanization, health concerns, changing consumer preferences, globalization and trade, and economic development. Sheep and goat pox vaccines are essential for safeguarding livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For instance, in February 2024, according to the Department for Environment, Food, and Rural Affairs, a UK-based government department, red meat production saw an uptick, notably with mutton and lamb production showing the largest increase at 2.9%. Therefore, the growing demand for livestock products is expected to propel the growth of the sheep and goat pox vaccines industry. The increasing investment in veterinary research and development (R&D) is expected to propel the growth of the sheep and goat pox vaccines market going forward. Investment in veterinary research and development (R&D) refers to the allocation of financial resources by governments, private institutions, and organizations toward studying, innovating, and creating new solutions to improve animal health, including the development of vaccines, treatments, diagnostic tools, and disease prevention strategies. Investment in veterinary R&D is rising due to increasing recognition of the need to innovate and improve animal health solutions in response to emerging and re emerging livestock diseases. Enhanced investment directly supports the development of more effective and safer vaccines for animal diseases. For instance, in May 2024, according to the Animal and Plant Health Inspection Service (APHIS), a U.S.-based government agency, the USDA awarded over $22.2 million to 81 new projects led by 48 states, universities, industry organizations, and veterinary diagnostic laboratories to strengthen prevention, preparedness, early detection, and rapid response to the most damaging diseases threatening U.S. livestock. Therefore, increasing investment in veterinary research and development (R&D) is driving the growth of the sheep and goat pox vaccines industry.

Key Players In The Global Sheep And Goat Pox Vaccines Market

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Santé Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

Global Sheep And Goat Pox Vaccines Market Trends and Insights

Major companies operating in the sheep and goat pox vaccines market are adopting a strategic partnerships approach to develop innovative vaccines. Strategic partnerships help the sheep and goat pox vaccines market by combining resources and expertise, advancing research and development, expanding market reach, and accelerating commercialization. For instance, in February 2024, Hester Biosciences, an India-based biotechnology and vaccine company, launched a PPR-Goatpox combined vaccine, integrating protection against Peste des Petits Ruminants (PPR) and Goatpox in a single formulation. The combined vaccine simplifies vaccination schedules, reduces handling stress, lowers vaccination costs, and improves overall flock health. This development followed a strategic technology transfer from the Indian Council of Agricultural Research–Indian Veterinary Research Institute (ICAR-IVRI), enabling Hester to commercialize the indigenous vaccine by leveraging IVRI’s research expertise alongside Hester’s manufacturing and distribution capabilities, thereby enhancing preventive livestock healthcare and vaccine accessibility in endemic regions

Regional Outlook

North America was the largest region in the sheep and goat pox vaccines market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Sheep And Goat Pox Vaccines Market?

The sheep and goat pox vaccines market consists of sales of recombinant vaccines and subunit vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.